Clinical Leader - Helping clinical research professionals connect and collaborate

CTD story - GettyImages-1253880092 and Canva

How Did You End Up In Clinical Research?

To commemorate Clinical Trials Day, we asked clinical researchers to share their story, answering, "How did you get into clinical research?"

GUEST COLUMNISTS

Designing Trials Patients Can Actually Complete: Lessons From The SWIFT Deep TMS Study
Being time conscious and attuned to patient needs are two contributing factors to trials that recruit and retain patients for the duration.
It's A Fact: Sharing Clinical Trial Results With Participants Builds Trust
CISCRP experts share results from their annual Perceptions & Insights Study showing that patients continue to place a high value on receiving both individual and overall study results.
When AI Agents Start Researching Trials On Behalf Of Patients, What Happens?
Right now, patients are using AI agents to find clinical trials. But soon enough, these AI tools will be doing it on their own and feeding patients the results. Recruitment expert Ross Jackson discusses this shift and what it will mean for sponsors.
The U.S. Clinical Trial Recruiting Pipeline Report – May 2026
This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from March 7 to May 1, 2026.
Safe And Scalable AI Deployment For Clinical Trials
When life sciences organizations lack a structured, evidence-based methodology for scaling AI tools safely and effectively, they put clinical development at risk. Partha Anbil and Partha Khot team up to share a practical approach to its implementation.
Small Biotech Survival: Navigating Risk And Capital Scarcity With AI
Maxine Opperman discusses the challenge and the necessity of small biotech's using AI, citing its pros, cons, and strategies for use.
5 Critical Risks With The FDA's Real-Time Trial Monitoring
Life science legal experts Kimberly Chew and Odette Hauke cover the FDA proof-of-concept real-time clinical trials (RTCTs) and expose five major issues that must be addressed before the pilot expands.
Executive Order For Psychedelics
We caught up with Joseph Tucker, Ph.D., CEO of Enveric Biosciences, to discuss the executive order for psychedelics.

CLINICAL TRIAL WHITE PAPERS

How Early-Stage Planning Strategies Are Optimizing Drug Development
Early integration of a target product profile (TPP) into early-stage planning is pivotal for steering drug development toward both regulatory success and commercial impact.

Safeguarding Personal Data: Protecting PII
8/4/2025

Learn about a secure, patient-centric platform that enables individuals to participate in clinical trials and registries while maintaining lifelong access to their data.
Human-Centered RTSM Design Enhances Data, Safety, And Operations
12/5/2025

Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.
Reducing Inventory Errors In Clinical Trials
5/8/2026

Can a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.
10 Clinical Research Practices That Feel Like Compliance (But Aren't)
3/24/2026

Many clinical research routines are driven by habit, not regulation. This guide clears up 10 common misconceptions to streamline workflows and reduce unnecessary admin work.
Remote Patient Monitoring Using Mobile Health Technology
3/28/2025

This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.

More Clinical Trial White Papers

CLINICAL TRIAL APP NOTES & CASE STUDIES

Setting A New Client Standard In Study Closeout Timelines
4/4/2025

Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.
Use Of Epiontis ID In A Phase 2 Psoriasis Trial
9/25/2025

Mirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.
Strategic Pre-IND Consulting For Gene Therapy In Rare Leukemia
4/11/2025

Learn about the collaborative efforts of an innovative biotech startup and Ergomed Consulting to overcome challenges in the pre-IND phase for a novel gene therapy targeting a rare form of leukemia.
Accelerating Early Phase Oncology Study Development
4/17/2025

Explore a close collaboration to co-develop a comprehensive, adaptive protocol designed to support key decisions across multiple trial phases for an innovative cancer therapy.
Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study
12/20/2024

This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.
GSK And Medable Discuss The Next Phase Of DCTs
3/10/2025

GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.

More Clinical Trial App Notes & Case Studies

NEWSLETTER ARCHIVE

More Newsletters

RECRUITMENT AND DIVERSITY

This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.

How Did You End Up In Clinical Research?

To commemorate Clinical Trials Day, we asked clinical researchers to share their story, answering, "How did you get into clinical research?"
When AI Agents Start Researching Trials On Behalf Of Patients, What Happens?

Right now, patients are using AI agents to find clinical trials. But soon enough, these AI tools will be doing it on their own and feeding patients the results. Recruitment expert Ross Jackson discusses this shift and what it will mean for sponsors.
The U.S. Clinical Trial Recruiting Pipeline Report – May 2026

This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from March 7 to May 1, 2026.

FOCUS ON PATIENTS

Designing Trials Patients Can Actually Complete: Lessons From The SWIFT Deep TMS Study

Being time conscious and attuned to patient needs are two contributing factors to trials that recruit and retain patients for the duration.
It's A Fact: Sharing Clinical Trial Results With Participants Builds Trust

CISCRP experts share results from their annual Perceptions & Insights Study showing that patients continue to place a high value on receiving both individual and overall study results.
Precision Medicine Needs Better Infrastructure — And We Already Have The Models For It

Standard methods for evaluating clinical trial representativeness perform poorly when the trial population differs from the broader disease population in a patient registry. June Cha, Ph.D., MPH, explains how the right metrics can make a difference.